Mark Agulnik

Section Chief of Sarcomas & Melanoma · University of Southern California/Los Angeles General Medical Center

Credentials: · · · ·

History

Sarcomas & Melanoma Section · University of Southern California/Los Angeles General Medical Center
Present
University of Southern California/Los Angeles General Medical Center
Present
University of Southern California/Los Angeles General Medical Center
Present

University of Toronto
2004–2006
Hematology and Medical Oncology
University of Illinois College of Medicine at Chicago
2001–2004
Internal Medicine
1998–2001
McGill University in Canada
Doctor of Medicine
1994–1998

Research

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
The Lancet · 2016 · 464 citations
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer
Journal of Clinical Oncology · 2014 · 419 citations
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Journal of Clinical Oncology · 2018 · 376 citations

BT
Brian Van Tine
21 papers
Steven Attia
14 papers
Scott Okuno
13 papers
Steven Robinson
9 papers
Brian Schulte
8 papers · 3 as a fellow
CR
Christopher Ryan
8 papers
Gary Schwartz
8 papers
Richard Riedel
8 papers
RM
Robert Maki
8 papers
SC
Sant Chawla
8 papers
SS
Scott Schuetze
8 papers
Seth Pollack
8 papers

Grants

The Robert H. Lurie Comprehensive Cancer Center
National Cancer Institute · P30
Project lead · $1.5M · Northwestern University

Clinical trials

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Principal investigator · Completed · Phase 2
Northwestern University
2015–2021
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
Principal investigator · Completed · Phase 2
Northwestern University
2014–2021
A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
Principal investigator · Completed · Phase 2
Northwestern University
2013–2016
Bevacizumab in Treating Patients With Angiosarcoma
Principal investigator · Completed · Phase 2
Northwestern University
2005–2016